GGrantIndex
Sort

261,768 grants matching gene therapy

CureSC Manufacturing Resource Platform

$1,303,054
Angelo A. Cardoso · Beckman Research Institute/City Of Hope · OT3 · FY2023 · HL

Targeting PTEN Null Tumors via Inhibition of the p110beta Isoform of PI3 Kinase

$1,302,860
Thomas M Roberts · Dana-Farber Cancer Inst · RC2 · FY2009 · CA

Somatic Mutations and Their Etiological Determinants for Breast Cancer in African American Women

$1,302,572
Song Yao · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA

The Monarch Initiative: Linking Diseases to Model Organism Resources

$1,302,478
Melissa A Haendel · Oregon State University · R24 · FY2018 · OD

Targeted Therapy in Neuroendocrine Cancer

$1,302,068
Samira Sadowski · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Sphingolipids in Cancer Biology and Therapy

$1,301,994
Yusuf Awni Hannun · State University New York Stony Brook · P01 · FY2017 · CA

Chemical Inhibitors to Define an Essential M. Tuberculosis Signaling Network

$1,301,887
Robert N Husson · Boston Children'S Hospital · R01 · FY2012 · AI

Immersive Simulation Program

$1,301,870
Susan Persky · National Human Genome Research Institute · ZID · FY2024 · HG

Effects of HIV SIV on unconventional T cells in immunity to M. tuberculosis in pre adolescents

$1,301,851
Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI

Modulation of cancer induced immune suppression via inhibition of SCD1

$1,301,808
Karen E Hayes · Modulation Therapeutics, Inc. · R44 · FY2023 · CA

Advancing RNA Therapeutics for Huntington’s Disease

$1,301,649
Neil Aronin · Univ Of Massachusetts Med Sch Worcester · U01 · FY2023 · NS

PIWI proteins and PIWI-interacting small RNAs guard the genomic integrity of germ cells

$1,301,322
Astrid Haase · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$1,301,281
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Engineered HSV for Treatment of Malignant Gliomas

$1,301,266
Richard J. Whitley · University Of Alabama At Birmingham · P01 · FY2006 · CA

Transplant Models

$1,301,254
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Immune Reconstitution

$1,301,254
Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Targeted Prevention for Non-Melanoma Skin Cancer

$1,301,234
Clara Curiel-Lewandrowski · University Of Arizona · P01 · FY2023 · CA

Molecular Mechanisms regulating membrane trafficking in salivary glands

$1,301,152
Roberto Weigert · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE

NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

$1,300,966
Elizabeth Phillips · Vanderbilt University Medical Center · U01 · FY2024 · AI

The Role of Protein Methylation in Squamous Cell Carcinoma of the Head and Neck

$1,300,908
Vassiliki Saloura · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Targeting the Tumor Vasculature to Treat Cancer

$1,300,808
Steven K. Libutti · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

PEARL: Pathway Exploration and Analysis in Renal Lupus

$1,300,724
Betty Diamond · Feinstein Institute For Medical Research · UH2 · FY2019 · AR

Investigating mechanisms of bladder tumorigenesis and therapeutic resistance

$1,300,700
Abdul Banday · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Host Defense Against HIV-related Pulmonary Infections

$1,300,680
Judd E Shellito · Lsu Health Sciences Center · P01 · FY2007 · HL

Genome Instability in Cancer Development

$1,300,592
Kyungjae Myung · National Human Genome Research Institute · ZIA · FY2011 · HG